Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-28T23:36:24.276Z Has data issue: false hasContentIssue false
  • English
  • Français

Emerging Public Health Law and Policy Issues Concerning State Medical Cannabis Programs

Published online by Cambridge University Press:  01 January 2021

William C. Tilburg ,
James G. Hodge Jr.  and
Camille Gourdet
Get access Rights & Permissions [Opens in a new window]

Abstract

Thirty-four states, the District of Columbia, and Puerto Rico have legalized medical cannabis. While no two state medical cannabis programs are alike, public health concerns related to advertising, packaging and labeling, pesticide use, scientific research, and the role of medical cannabis in the opioid crisis are emerging across the country. This article examines these issues, the policy approaches states are adopting to protect patients and the public, and an assessment of the underlying federal legal landscape.

Type
Symposium Articles
Information
Journal of Law, Medicine & Ethics , Volume 47 , Issue S2: 2018 Public Health Law Conference: Health Justice: Empowering Public Health and Advancing Health Equity , Summer 2019 , pp. 108 - 111
Copyright
Copyright © American Society of Law, Medicine and Ethics 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

National Conference of State Legislatures, State Medical Marijuana Laws (2018), available at <http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx> (last visited May 8, 2019).+(last+visited+May+8,+2019).>Google Scholar
U.S. Census Bureau, State Population Totals and Components of Change: 2010-2017 (2018).Google Scholar
U.S. DEA, Cannabis Eradication: Domestic Cannabis Eradication/Suppression Program, available at <https://www.dea.gov/cannabis-eradication> (last visited May 8, 2019).+(last+visited+May+8,+2019).>Google Scholar
U.S. Department of Justice, “Guidance Regarding Marijuana Enforcement,” August 29, 2013.Google Scholar
United States v. Gilmore, 886 F.3d 1288, 1289 (9th Cir. 2018)Google Scholar
National Academy of Medicine, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (2017), available at <https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state> (last visited May 8, 2019).+(last+visited+May+8,+2019).>Google Scholar
Hoffmann, D., Palumbo, F. B., and Yang, Y. Tony, Will The FDA's Approval Of Epidiolex Lead To Rescheduling Marijuana?, July 12, 2018, available at <https://www.healthaf-fairs.org/do/10.1377/hblog20180709.904289/full/> (last visited May 8, 2019). (last visited May 8, 2019).' href=https://scholar.google.com/scholar?q=Hoffmann,+D.,+Palumbo,+F.+B.,+and+Yang,+Y.+Tony,+Will+The+FDA's+Approval+Of+Epidiolex+Lead+To+Rescheduling+Marijuana?,+July+12,+2018,+available+at++(last+visited+May+8,+2019).>Google Scholar
H.R. 5520, 115th Cong. (2018)Google Scholar
H.R. 5634, 115th Cong. (2018)Google Scholar
S. 3032, 115th Cong. (2018); H.B. 6043, 115th Cong. (2018).Google Scholar
Washington State Liquor and Cannabis Board, Not for Kids Warning Symbol, available at <http://lcb.wa.gov/marj/warning-symbol-article> (last visited May 8, 2019).+(last+visited+May+8,+2019).>Google Scholar
Ariz. Admin. Code § R9-17-317 (2018)CrossRefGoogle Scholar
Colo. Code Regs. § 212-1 (2018)Google Scholar
006 02 Ark. Code. R. § 007 (2018)CrossRefGoogle Scholar
Fla. Stat. § 381.986 (2018)Google Scholar
N.Y. Comp. Codes R. & Regs. tit. 10, § 1004.16 (2018)CrossRefGoogle Scholar
State of Nevada Department of Agriculture, Pesticide Use on Medical Marijuana, available at <http://agri.nv.gov/upload-edFiles/agrinvgov/Content/Plant/Environmental_Compliance/MME%20Pesticide%20list-%2001-09-2017%20Updated.pdf> (last visited May 8, 2019).+(last+visited+May+8,+2019).>Google Scholar
007 16 Ark. Code. R. § 005 (LexisNexis 2018)CrossRefGoogle Scholar
N.Y. Comp. Codes R. & Regs. tit. 10, § 1004.2 (2018)Google Scholar
National Academies of Sciences, Engineering, and Medicine, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (2017).Google Scholar
Bachhuber, M. A., Saloner, B., and Cunningham, C. O., “Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010,” JAMA Internal Medicine 174, no. 10 (2014): 1668-1673.CrossRefGoogle Scholar
Bradford, A. C., Bradford, W. D., and Abraham, A., “Association between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population,” JAMA Internal Medicine 178, no. 5 (2018): 667-672.CrossRefGoogle Scholar
S.B. 2407, 29th Leg., Reg. Sess. (Haw. 2018)Google Scholar
L.D. 1539, 128th Leg., Spec. Sess. (Me. 2018)Google Scholar
H.B. 527, 53rd Leg., Reg. Sess. (N.M. 2017)Google Scholar
American Civil Liberties Foundation, The War on Marijuana in Black and White (2013).Google Scholar
Marijuana Business Daily, Women and Minorities in the Marijuana Industry (2017), available at <https://mjbizdaily.com/wp-content/uploads/2017/10/Women-and-Minorities-Report.pdf> (last visited May 8, 2019).+(last+visited+May+8,+2019).>Google Scholar
935 CMR 500.105 (2018); Los Angeles, California, Municipal Code § 104.20 (2018); Oakland, California, Municipal Code § 5.80.045 (2018).Google Scholar
28 PA. Code § 1141.32 (2018)Google Scholar
Ohio Rev. Code Ann. §3796.09 (2018)Google Scholar
PharmaCann Ohio, LLC v. Ohio Dept. of Comm., Franklin C.P. No. 17 CV 10962 (2018).Google Scholar